Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Legionnaire Disease Genetics
Researchers from Wadsworth Center, New York State Department of Health provide details of new studies and findings in the area of legionnaire disease genetics
November 9th, 2008
Current study results from the report, 'Design and implementation of a protocol for the detection of Legionella in clinical and environmental samples,' have been published. "Our laboratory has developed a novel real-time polymerase chain reaction (PCR) assay for the detection of Legionella pneumophila and differentiation from other Legionella spp. in clinical and environmental samples. The 23S rRNA gene was used as a target to detect all Legionella spp., and the mip gene was targeted for the specific detection of L. pneumophila in this multiplex Taqman real-time PCR assay," investigators in the United States report. "The 23S rRNA gene is a novel target for...
Source: Medical Letter on the CDC & FDA (2008-11-09)
|
